Advanced donor-origin melanoma in a renal transplant recipient: immunotherapy, cure, and retransplantation.
暂无分享,去创建一个
P. Hogan | C. Hawley | R. Rigby | M. Suranyi | M. Falk | R. Axelsen | J. Petrie
[1] P. Hersey,et al. Remission of transplanted melanoma--clinical course and tumour cell characterisation. , 1997, Clinical transplantation.
[2] K. Kishi,et al. The heterogeneous expression of CD80, CD86 and other adhesion molecules on leukemia and lymphoma cells and their induction by interferon. , 1997, Journal of experimental & clinical cancer research : CR.
[3] N. Mcfarland,et al. Control of Islet Intercellular Adhesion Molecule-1 Expression by Interferon-α and Hypoxia , 1996, Diabetes.
[4] I. Penn. Malignant melanoma in organ allograft recipients. , 1996, Transplantation.
[5] John P. Johnson,et al. INTERFERON-α-INDUCED ACUTE RENAL ALLOGRAFT REJECTION , 1995 .
[6] C. Scheibenbogen,et al. Detection of Residual Tumor Cells in Patients with Malignant Melanoma Responding to Immunotherapy , 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[7] I. Penn. Malignancy in transplanted organs , 1993, Transplant international : official journal of the European Society for Organ Transplantation.
[8] R. Horvat,et al. Identification of donor melanoma in a renal transplant recipient. , 1992, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[9] J. Kirkwood,et al. Role of Interferons in the Thearpy of Melanoma , 1990 .
[10] H. Koeppen,et al. Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen , 1990, The Journal of experimental medicine.
[11] F. Sanfilippo. The transmission of disease to allograft recipients via donor organs. , 1989, Current opinion in immunology.
[12] I. Fidler,et al. Direct antiproliferative effects of recombinant human interferon-alpha B/D hybrids on human tumor cell lines. , 1987, Cancer research.
[13] M. Suranyi,et al. Target susceptibility in cell-mediated lympholysis assays correlates with major histocompatibility complex surface antigen expression. , 1987, Transplantation proceedings.
[14] G. Duggin,et al. EXPRESSION OF HLA ANTIGENS ON RENAL TUBULAR CELLS IN CULTURE: I. EVIDENCE THAT MIXED LYMPHOCYTE CULTURE SUPERNATANTS AND GAMMA INTERFERON INCREASE BOTH CLASS I AND CLASS II HLA ANTIGENS , 1986, Transplantation.
[15] J. Jeekel,et al. RECOMBINANT LEUCOCYTE INTERFERON A INDUCES STEROID-RESISTANT ACUTE VASCULAR REJECTION EPISODES IN RENAL TRANSPLANT RECIPIENTS , 1984, The Lancet.
[16] S. Pestka,et al. Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes. , 1982, Cellular immunology.
[17] L. Harvey,et al. Transferral of malignancy as a complication of organ transplantation: an insuperable problem? , 1981, Journal of clinical pathology.
[18] P. Sweny,et al. MALIGNANT MELANOMA IN PATIENT WITH RENAL TRANSPLANT , 1980, The Lancet.
[19] R. Fairman,et al. INADVERTENT TRANSPLANTATION OF A MELANOMA , 1980, Transplantation.
[20] M. Peters,et al. Metastatic malignant melanoma transplanted via a renal homograft. A case report , 1978, Cancer.
[21] M. Seller. SCREENING FOR NEURAL-TUBE DEFECTS , 1975, The Lancet.
[22] Glasg Mb,et al. Martha Graham Robson. , 1975 .
[23] R. Farnsworth,et al. Transplantation of malignant melanoma with cadaver kidney. , 1972, Transplantation.
[24] C. Zukoski,et al. Transplanted carcinoma in an immunosuppressed patient. , 1970, Transplantation.
[25] R. Wilson,et al. Immunologic rejection of human cancer transplanted with a renal allograft. , 1968, The New England journal of medicine.
[26] M. Rubini,et al. CADAVERIC RENAL HOMOTRANSPLANTATION WITH INADVERTENT TRANSPLANTATION OF CARCINOMA. , 1965, JAMA.